Editorial Team

Neuroanatomy and Behaviour is edited by volunteers who are active scientists and, in many cases, emerging leaders in their fields. Please note, links to editor profiles are to external websites.

Managing Editor/Editor-in-Chief

Shaun Khoo
Université de Montréal, Canada.
Shaun studies the neuropharmacology of appetitive motivation in animal models of addiction and appetitive motivation. He also has interests in animal welfare, ethics, and open science. He is the President of Episteme Health Inc and is supported by a postdoctoral fellowship from the Fonds de Recherche du Québec - Santé.

Research Integrity Editors

Otto Kalliokoski [Institutional Profile]
University of Copenhagen, Denmark.
Dr Kalliokoski is laboratory animal researcher focusing on measurement methods, primarily within the fields of stress and depression research.


Kelly Clemens [Institutional Profile]
University of New South Wales, Australia.
Dr Clemens studies the neurobiology of drug addiction, particularly with respect to psychostimulants such as nicotine. She is interested in epigenetic factors, choice paradigms, and habits.

Joanna Yau [ResearchGate]
University of New South Wales, Australia.
Dr Yau uses chemo- and optogenetic techniques in combination with animal models of learning and motivation to study the neurobiology of fear conditioning. She is the Vice-President of Episteme Health Inc.

Nicola Chen [ResearchGate]
Black Dog Institute, University of New South Wales, Australia.
Dr Chen has expertise in neuropharmacology using animal models of alcohol addiction. She is the Secretary of Episteme Health Inc.

Belinda Lay [Institutional Profile]
Concordia University, Canada.
Dr Lay uses transgenic rats and neuropharmacology to isolate the role of specific neuronal ensembles in extinction learning. She is an expert on the intracellular mechanisms of higher order Pavlovian learning. She is the Treasurer of Episteme Health Inc and is supported by a postdoctoral fellowship from the Fonds de Recherche du Québec - Santé.

Rose Chesworth [Institutional Profile]
Western Sydney University, Australia.
Dr Chesworth studies the neurobiology, pharmacology, and genetics underlying mental disorders using behavioural approaches and transgenic mice. She has worked with models of methamphetamine addiction and is currently interested in the neurogenetics of schizophrenia. She is a member of the committee of management of Episteme Health Inc.

Dominic Tran [Institutional Profile]
University of Sydney, Australia.
Dr Tran is an expert on the interactions between diet, brain, and behaviour with work spanning both human and animal models of learning, memory, and motor control. He is a member of the committee of management of Episteme Health Inc.

Sarah Ch'ng [Institutional Profile]
Florey Institute of Neuroscience and Mental Health, University of Melbourne, Australia.
Dr Ch'ng studies the neurobiology of innate behaviours using transgenic mice, neuropharmacology, and chemogenetics. She is interested in how neuropeptide systems in the extended amygdala regulate highly innate behaviours, including salt appetite and parental care.

Erin Campbell [Institutional Profile] [Personal Website]
Florey Institute of Neuroscience and Mental Health, University of Melbourne, Australia.
Dr Campbell has expertise in the use of chemogenetic techniques and animal models of alcohol addiction. She is particularly interested in the neural circuits involved in relapse, such as the lateral hypothalamus and nucleus accumbens shell.

Robyn Brown [Institutional Profile]
Florey Institute of Neuroscience and Mental Health, University of Melbourne, Australia.
Dr Brown studies the neurobiology of compulsive eating and drug addiction using electrophysiology in animal models. She is currently an NHMRC R.D. Wright Biomedical Career Development Fellow.

Sydney Trask [Institutional Profile]
University of Wisconsin-Milwaukee, United States.
Dr Trask is interested in the neurobiological mechanisms of fear memory formation and destabilisation. She has utilised both Pavlovian and operant animal models to study learning mechanisms and their environmental and neuroanatomical influences.

Heidi Meyer [Institutional Profile]
Weill Cornell Medical College, United States.
Dr Meyer studies anxiety disorders using mouse models of fear conditioning. Her research focuses on the neurobiological aspects of learning about safety signals that are particular to adolescence.

Steven Simmons [ResearchGate]
Childrens Hospital of Philadelphia, United States.
Dr Simmons is an addiction neuroscientist who studies circuitry underlying the reinforcing effects of self-administered drugs like cocaine and oxycodone. His current work explores how contextual stimuli become imbued with drug-craving properties over the course of drug use, and how hippocampal circuits can be targeted to protect against relapse.

Joseph Ziminski [Institutional Profile]
University of Sussex, United Kingdom.
Dr Ziminski is an addiction neuroscientist who studies psychostimulant abuse using rodent models. His work combines transgenic mice, pharmacology, and slice electrophysiology to examine the neuronal ensembles involved in reward and motivation.

Desiree Seib [Institutional Profile]
University of British Columbia, Canada.
Dr Seib studies the role of the hippocampus in neurogenesis and depression. She uses tools such as pharmacology, molecular techniques, and transgenic animal models to manipulate these neurons at different stages of an animal's life.

Maria Carmen Medrano [ResearchGate]
Neurocentre Magendie, France.
Dr Medrano is interested in the neuropathologies underlying disorders from addiction and Alzheimer's disease to neuropathic pain. She is an experienced pharmacologist and electrophysiologist (in vitro and in vivo) who is currently using patch clamp recordings to study the effect of natural rewards, like exercise, on key brain regions such as ventral tegmental area.

Sarah Baracz [Institutional Profile]
Macquarie University, Australia.
Dr Baracz studies the neurobiological link between early life stress exposure and increased vulnerability for mental illness including drug addiction. She has expertise in the oxytocin system, the psychostimulant drug methamphetamine, and neuroinflammatory markers.

Amanda Wright [Institutional Profile]
Macquarie University, Australia.
Dr Wright studies mouse models of neurodegenerative disorders including Alzheimer's disease and Motor Neuron Disease. She has expertise in neuroinflammatory pathways, excitotoxicity and behavioural deficits in a range of transgenic mouse models.

Reviewing Editors

Danielle Gerhard [Institutional Profile]
Weill Cornell Medical College, United States.
Dr Gerhard is a behavioural neuroscientist who studies the neurobiology of anxiety- and mood-related disorders using rodent models. Her current research focuses the development of anxiety-related behaviors and the neural circuits mediating these behaviors, with a particular interest in adolescent development.

Konrad Schöttner [ResearcherID]
Concordia University, Canada.
Dr Schöttner uses rodent models, including transgenic mouse lines, to study central nervous system regulation of circadian rythyms.

Christina Mo [Institutional Profile]
University of Chicago, United States.
Dr Mo studies neural circuits involved in higher order sensory processing using techniques such as viral tracing, optogenetics, electrophysiology and behaviour.

Shawn Tan [Institutional Profile]
University of Hong Kong, Hong Kong Special Administrative Region.
Mr Tan has experience in neuropharmacology, rodent models of fear and memory, neuromodulation, and neurovirology.

Justine Fam [Institutional Profile]
UNSW Sydney, Australia
Dr Fam is a postdoctoral researcher in the School of Psychology at UNSW Sydney. Her doctoral work examined the temporal dynamics and behavioural correlates of decision-making. Her current work focuses on the neural mechanisms underpinning higher-order conditioning and the neuromodulatory effects of oxytocin on learning and memory. Justine hopes to contribute to a better understanding of the mechanisms that underlie learning and memory by pairing neuroscience techniques with detailed analyses of behaviour.

Piotr Popik [Institutional Profile]
Institute of Pharmacology, Polish Academy of Sciences, Poland.
Prof Popik is the head of Department of Behavioral Neuroscience & Drug Development, where he works on behavioural psychopharmacology and cognition. His lab frequently collaborates with drug companies and uses a diverse range of behavioural paradigms, including aversive conditioning, drug discrimination, and rodent models of schizophrenia.